Articlegold2021

Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication

Jerome Nyhalah Dinga · Leontine Kouemou Sinda · Vincent P. K. Titanji

174 citations0/0 files storedVaccines

No readable copy stored yet — this record is metadata only.

Vaccine Coverage and Hesitancy SARS-CoV-2 and COVID-19 Research COVID-19 and Mental Health

Abstract

Since the outbreak of COVID-19 in December 2019, no global consensus treatment has been developed and generally accepted for the disease. However, eradicating the disease will require a safe and efficacious vaccine. In order to prepare for the eventual development of a safe and efficacious COVID-19 vaccine and to enhance its uptake, it is imperative to assess vaccine hesitancy in Cameroonians. After obtaining ethical clearance from the Institutional Review Board of the University of Buea, a questionnaire was administered (May-August 2020) to consenting adults either online or in person. A qualitative thematic analysis was done to analyze the participants' answers to the open questions. A deductive approach was used, that is, the codes and patterns according to the World Health Organization (WHO) Strategic Advisory Group of Experts (SAGE) Working Group Matrix of Determinants of vaccine hesitancy. The number of consenting adult Cameroonians who completed the questionnaire were 2512 (Two thousand five hundred and twelve). Vaccine hesitancy to a COVID-19 vaccine was 84.6% in Cameroonians. Using the WHO recommended Matrix of Determinant of Vaccine hesitancy, the most prominent determinants observed in this study were: Communication and Media Environment, Perception of pharmaceutical industry, Reliability and/or source of vaccine and cost. Most Cameroonians agree that even though there are benefits of a clinical trial, they will prefer it should be done out of the continent and involving African scientists for eventual acceptance and uptake. The concerns of safety, efficacy and confidence has to be addressed using a Public Engagement approach if a COVID-19 vaccine has to be administered successfully in Africa or Cameroon specifically. Since this study was carried out following WHO standards, its result can be compared to those of other studies carried out in different cultural settings using similar standards.

Citations in this library

Stored only when both papers are in the corpus — 174 citations exist upstream.

References

2006Using thematic analysis in psychology 2015Vaccine hesitancy: Definition, scope and determinants 2012Computing Inter-Rater Reliability for Observational Data: An Overview and Tutorial 2014Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012 2013Vaccine hesitancy 2011Anti-vaccine activists, Web 2.0, and the postmodern paradigm – An overview of tactics and tropes used online by the anti-vaccination movement 2014Mapping vaccine hesitancy—Country-specific characteristics of a global phenomenon 2018Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017

Cited by

2021Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis 2022Trust is the common denominator for COVID-19 vaccine acceptance: A literature review 2022COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis 2021Addressing challenges to rolling out COVID-19 vaccines in African countries 2021Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya

Imported from OpenAlex (CC0) — nothing here is generated.